• Medical Policies

    Premera offers access to more than 300 medical policies online. Since we’re continually updating these pages, we encourage you to visit often. The policies are in Adobe PDF format. Individual plans use different medical policies. View individual plan medical policies and also View our HMO medical policies.

    Enter one or more keywords. Enter "policy" to see a complete list of policies.

* One or more keywords are required

  Reset search
467 results found for policy
https://www.premera.com/medicalpolicies/15.01.006.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.006 Parathyroid Hormone, Phosphorus, Calcium, and Magnesium Testing Ref. Policy: G2164 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, ...
https://www.premera.com/medicalpolicies/15.01.021.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.021 Gamma-glutamyl Transferase Testing in Adults Ref. Policy: G2173 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, 2025 Replaces: N/A ...
https://www.premera.com/medicalpolicies/15.01.029.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.029 Vitamin B12 and Methylmalonic Acid Testing Ref. Policy: G2014 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, 2025 Replaces: N/A ...
https://www.premera.com/medicalpolicies/15.01.044.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.044 Therapeutic Drug Monitoring for 5-Fluorouracil Ref. Policy: M2067 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, 2025 Replaces: N/A ...
https://www.premera.com/medicalpolicies/15.01.047.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.047 Venous and Arterial Thrombosis Risk Testing Ref. Policy: M2041 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, 2025 Replaces: N/A ...
https://www.premera.com/medicalpolicies/15.01.049.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.049 Testing of Homocysteine Metabolism-Related Conditions Ref. Policy: M2141 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, 2025 ...
https://www.premera.com/medicalpolicies/15.01.052.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.052 Serum Biomarker Testing for Multiple Sclerosis and Related Neurologic Diseases Ref. Policy: G2123 Effective Date: Feb. 6, 2026 Last ...
https://www.premera.com/medicalpolicies/4.02.503.pdf#search=policy
Assisted Reproduction Services BCBSA Ref. Policy 4.02.04 Effective Date: Nov. 1, 2025 Last ... section is for your general knowledge and is not to be taken as policy coverage criteria. ...
https://www.premera.com/medicalpolicies/15.01.025.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.025 Pancreatic Enzyme Testing for Acute Pancreatitis Ref. Policy: G2153 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, 2025 Replaces: N/...
https://www.premera.com/medicalpolicies/15.01.034.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.034 Biomarkers for Myocardial Infarction and Chronic Heart Failure Ref. Policy: G2150 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, ...
https://www.premera.com/medicalpolicies/15.01.038.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.038 In Vitro Chemoresistance and Chemosensitivity Assays Ref. Policy: G2100 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, 2025 ...
https://www.premera.com/medicalpolicies/15.01.039.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.039 Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing Ref. Policy: G2060 Effective Date: Feb. ...
https://www.premera.com/medicalpolicies/15.01.051.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.051 Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease Ref. Policy: G2121 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, ...
https://www.premera.com/medicalpolicies/15.01.013.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.013 Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease Ref. Policy: G2110 Effective Date: Feb. 6, ...
https://www.premera.com/medicalpolicies/15.01.033.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.033 Epithelial Cell Cytology in Breast Cancer Risk Assessment Ref. Policy: G2059 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, 2025 ...
https://www.premera.com/medicalpolicies/15.01.035.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.035 Immunopharmacologic Monitoring of Therapeutic Serum Antibodies Ref. Policy: G2105 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, ...
https://www.premera.com/medicalpolicies/15.01.050.pdf#search=policy
ROUTINE TEST MANAGEMENT POLICY - 15.01.050 Urinary Tumor Markers for Bladder Cancer Ref. Policy: G2125 Effective Date: Feb. 6, 2026 Last Revised: Oct. 14, 2025 Replaces: N/A ...
https://www.premera.com/medicalpolicies/10.01.518.pdf#search=policy
This policy provides background about different types of studies, outlines what services ... section is for your general knowledge and is not to be taken as policy coverage criteria. ...
https://www.premera.com/medicalpolicies/11.01.510.pdf#search=policy
May 1, 2024* Last Revised: April 8, 2024 Replaces: N/A *This policy has been revised. ... This policy describes when skilled care in a skilled nursing facility may be considered ...
https://www.premera.com/medicalpolicies/9.02.502.pdf#search=policy
below to be redirected to that section. POLICY CRITERIA | DOCUMENTATION REQUIREMENTS | ... Untreated periodontal disease can lead to tooth loss. This policy describes dentally ...